<DOC>
	<DOCNO>NCT01692301</DOCNO>
	<brief_summary>The study examine efficacy LCZ696 comparison ARB olmesartan Central Aortic Systolic Blood Pressure ( CASP ) measure central hemodynamics arterial stiffness elderly patient elevate systolic blood pressure ( SBP ) widen pulse pressure ( PP ) .</brief_summary>
	<brief_title>Study Safety Efficacy LCZ696 Arterial Stiffness Elderly Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<criteria>Key 1 . Male female patient ≥ 60 year age . 2 . Patients essential hypertension , untreated currently take antihypertensive therapy . 3 . Untreated patient must office msSBP ≥150 mmHg &lt; 180 mmHg Visit 101 Visit 201 newly diagnose treat antihypertensive drug 4 week prior Visit 1 . 4 . Treated patient must office msSBP ≥140 mmHg &lt; 180 mmHg Visit 102 ( Visit 103 ) msSBP ≥150 mmHg &lt; 180 mmHg Visit 201 treat antihypertensive drug 4 week prior Visit 1 . 5 . All patient must pulse pressure &gt; 60 mmHg Visit 201 . Pulse pressure define msSBP msDBP . 6 . Patients must difference msSBP within +/15 mmHg Visit 201 ( randomization ) visit immediately prior Visit 201 . Key 1 . Malignant severe hypertension ( grade 3 WHO classification ; msDBP ≥110 mmHg and/or msSBP ≥ 180 mmHg ) 2 . History angioedema , drugrelated otherwise . 3 . History evidence secondary form hypertension , include limited following : renal parenchymal hypertension , renovascular hypertension ( unilateral bilateral renal artery stenosis ) , coarctation aorta , primary hyperaldosteronism , Cushing 's disease , pheochromocytoma , polycystic kidney disease , druginduced hypertension . 4 . Transient ischemic cerebral attack ( TIA ) 12 month prior Visit 1 history stroke . 5 . History myocardial infarction , coronary bypass surgery percutaneous coronary intervention ( PCI ) 12 month prior Visit 1 . 6 . History atrial fibrillation atrial flutter 3 month prior Visit 1 , active atrial fibrillation atrial flutter ECG screening .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hypertension , elderly , central aortic pulse pressure , central pulse pressure , pulse wave velocity</keyword>
</DOC>